PL3162363T3 - Preparat złożony zawierający warstwę powłoki filmu zawierającą składnik aktywny - Google Patents
Preparat złożony zawierający warstwę powłoki filmu zawierającą składnik aktywnyInfo
- Publication number
- PL3162363T3 PL3162363T3 PL15816054T PL15816054T PL3162363T3 PL 3162363 T3 PL3162363 T3 PL 3162363T3 PL 15816054 T PL15816054 T PL 15816054T PL 15816054 T PL15816054 T PL 15816054T PL 3162363 T3 PL3162363 T3 PL 3162363T3
- Authority
- PL
- Poland
- Prior art keywords
- active ingredient
- coating layer
- film coating
- containing film
- composite preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20140081223 | 2014-06-30 | ||
PCT/KR2015/006743 WO2016003181A1 (ko) | 2014-06-30 | 2015-06-30 | 활성성분-함유 필름 코팅층을 포함하는 복합제제 |
EP15816054.9A EP3162363B1 (en) | 2014-06-30 | 2015-06-30 | Composite preparation comprising active ingredient-containing film coating layer |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3162363T3 true PL3162363T3 (pl) | 2020-06-15 |
Family
ID=55169028
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL15815459T PL3150201T3 (pl) | 2014-06-30 | 2015-06-30 | Preparat kompozytowy zawierający błonową warstwę powlekającą zawierającą inhibitor 5-reduktazy i sposób wytwarzania preparatu kompozytowego |
PL15816054T PL3162363T3 (pl) | 2014-06-30 | 2015-06-30 | Preparat złożony zawierający warstwę powłoki filmu zawierającą składnik aktywny |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL15815459T PL3150201T3 (pl) | 2014-06-30 | 2015-06-30 | Preparat kompozytowy zawierający błonową warstwę powlekającą zawierającą inhibitor 5-reduktazy i sposób wytwarzania preparatu kompozytowego |
Country Status (8)
Country | Link |
---|---|
EP (2) | EP3162363B1 (pl) |
KR (3) | KR20160002411A (pl) |
CN (2) | CN106659690B (pl) |
ES (2) | ES2772137T3 (pl) |
PH (2) | PH12016502537A1 (pl) |
PL (2) | PL3150201T3 (pl) |
PT (2) | PT3150201T (pl) |
RU (1) | RU2696563C9 (pl) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170113459A (ko) * | 2016-03-31 | 2017-10-12 | 한미약품 주식회사 | 타다라필 및 암로디핀 함유 고형 복합제제 |
MX2018011642A (es) * | 2016-03-31 | 2019-03-14 | Hanmi Pharm Ind Co Ltd | Preparacion en capsula compuesta que contiene tadalafilo y tamsulosina con estabilidad y tasa de elucion mejoradas. |
WO2019035679A2 (ko) | 2017-08-18 | 2019-02-21 | (주)인벤티지랩 | 피나스테라이드를 포함하는 마이크로 입자 및 이의 제조 방법 |
KR20200099901A (ko) | 2019-02-15 | 2020-08-25 | (주)인벤티지랩 | 피나스테라이드를 포함하는 마이크로 입자를 함유한 피하 주사용 조성물 |
KR102157124B1 (ko) | 2019-12-23 | 2020-09-18 | (주)인벤티지랩 | 피나스테라이드를 포함하는 서방성 주사용 조성물 |
US20240075028A1 (en) | 2020-12-31 | 2024-03-07 | Dong Kook Pharm. Co., Ltd. | Pharmaceutical composition comprising tadalafil or pharmaceuticallly acceptable salt thereof and dutasteride or pharmaceuticallly acceptable salt thereof exhibiting novel dissolution rate |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005016981A1 (de) * | 2005-04-13 | 2006-10-19 | Bayer Healthcare Ag | Kombination zur Therapie bei benigner Prostatahyperplasie |
EP2210595A1 (en) * | 2009-01-14 | 2010-07-28 | LEK Pharmaceuticals d.d. | Active coating of pharmaceutical dosage forms |
EP2515882A2 (en) * | 2009-12-22 | 2012-10-31 | Abbot Healthcare Private Limited | Controlled release pharmaceutical composition |
KR101193495B1 (ko) * | 2010-02-01 | 2012-10-23 | 한미사이언스 주식회사 | 슈도에페드린 및 레보세티리진을 포함하는 경구용 복합 조성물 |
WO2012127495A2 (en) * | 2011-02-28 | 2012-09-27 | Titan Laboratories Pvt. Ltd. | A pharmaceutical composition and process for preparation thereof |
KR101310710B1 (ko) * | 2011-03-23 | 2013-09-27 | 한미약품 주식회사 | 오메가-3 지방산 에스테르 및 HMG-CoA 환원효소 억제제를 포함하는 경구용 복합 조성물 |
KR20140013436A (ko) * | 2012-07-24 | 2014-02-05 | 한미약품 주식회사 | 메트포르민 및 로수바스타틴을 포함하는 경구용 복합 제제 |
KR102240429B1 (ko) * | 2013-05-06 | 2021-04-15 | 한미약품 주식회사 | 로수바스타틴 또는 이의 약학적으로 허용되는 염이 함유된 필름 코팅층을 포함하는 복합 제형 |
WO2014182003A1 (en) * | 2013-05-06 | 2014-11-13 | Hanmi Pharm. Co., Ltd. | Composite formulation comprising a film coating layer containing rosuvastatin or a pharmaceutically acceptable salt thereof |
-
2015
- 2015-06-30 CN CN201580033728.7A patent/CN106659690B/zh not_active Expired - Fee Related
- 2015-06-30 EP EP15816054.9A patent/EP3162363B1/en active Active
- 2015-06-30 EP EP15815459.1A patent/EP3150201B1/en active Active
- 2015-06-30 KR KR1020150093777A patent/KR20160002411A/ko active Search and Examination
- 2015-06-30 KR KR1020150093778A patent/KR101780739B1/ko active IP Right Grant
- 2015-06-30 RU RU2016148824A patent/RU2696563C9/ru active
- 2015-06-30 PL PL15815459T patent/PL3150201T3/pl unknown
- 2015-06-30 PT PT158154591T patent/PT3150201T/pt unknown
- 2015-06-30 PT PT158160549T patent/PT3162363T/pt unknown
- 2015-06-30 PL PL15816054T patent/PL3162363T3/pl unknown
- 2015-06-30 ES ES15816054T patent/ES2772137T3/es active Active
- 2015-06-30 CN CN201580035935.6A patent/CN106659692B/zh not_active Expired - Fee Related
- 2015-06-30 ES ES15815459T patent/ES2781110T3/es active Active
-
2016
- 2016-12-19 PH PH12016502537A patent/PH12016502537A1/en unknown
- 2016-12-19 PH PH12016502536A patent/PH12016502536A1/en unknown
-
2017
- 2017-02-24 KR KR1020170025042A patent/KR101780740B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CN106659692A (zh) | 2017-05-10 |
CN106659690A (zh) | 2017-05-10 |
PT3162363T (pt) | 2020-02-21 |
EP3150201B1 (en) | 2020-02-19 |
PL3150201T3 (pl) | 2020-09-21 |
KR101780740B1 (ko) | 2017-09-26 |
PH12016502537A1 (en) | 2017-04-10 |
EP3162363A4 (en) | 2018-01-03 |
KR20170026424A (ko) | 2017-03-08 |
EP3150201A1 (en) | 2017-04-05 |
KR101780739B1 (ko) | 2017-09-26 |
RU2016148824A3 (pl) | 2018-10-10 |
RU2016148824A (ru) | 2018-07-30 |
EP3162363A1 (en) | 2017-05-03 |
ES2772137T3 (es) | 2020-07-07 |
KR20160002411A (ko) | 2016-01-07 |
EP3162363B1 (en) | 2020-01-08 |
RU2696563C2 (ru) | 2019-08-05 |
RU2696563C9 (ru) | 2019-10-02 |
EP3150201A4 (en) | 2018-01-03 |
PT3150201T (pt) | 2020-03-31 |
ES2781110T3 (es) | 2020-08-28 |
CN106659690B (zh) | 2020-08-18 |
KR20160002412A (ko) | 2016-01-07 |
PH12016502536A1 (en) | 2017-04-10 |
CN106659692B (zh) | 2020-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1219064A1 (zh) | 藥物塗層 | |
EP3229851A4 (en) | Medical device coating with a biocompatible layer | |
HK1218260A1 (zh) | 包含含有瑞舒伐他汀或其可藥用鹽的膜包衣層的複合製劑 | |
PL2990195T3 (pl) | Wielowarstwowa folia kompozytowa z wytłoczonym wzorem i laminowana w postaci stopu | |
EP3315571A4 (en) | Coating film | |
EP3029092A4 (en) | Coating film | |
EP3347306A4 (en) | GRAPHENE-BASED CIRCULAR MATERIALS WITH LOW NUMBER OF LAYERS | |
EP3238236A4 (en) | Via blocking layer | |
EP3388237A4 (en) | MULTILAYER FILM WITH HARD COATING | |
PT3162363T (pt) | Preparação compósita que compreende uma camada de revestimento de película contendo um ingrediente ativo | |
EP3202395A4 (en) | Soft capsule coating film | |
EP3354690A4 (en) | OXYGEN PERMEABLE FOIL | |
DK3623426T3 (en) | Polymer-metal compound composite ink and preparation method and use thereof | |
EP3122337A4 (en) | Abuse deterrent immediate release coated reservoir solid dosage form | |
EP3057792A4 (en) | Breathable composite film | |
EP3475973A4 (en) | BLOCKING LAYER FOR CONTACT | |
EP3023452A4 (en) | Coated film | |
PL2727724T3 (pl) | Folia jednowarstwowa lub wielowarstwowa | |
EP3165630A4 (en) | Hard coating film | |
EP3130461A4 (en) | Composite film and method for manufacturing same | |
EP3050702A4 (en) | Coated film | |
ZA201707811B (en) | Silicone gel-coated adhesive layer structure | |
EP3109893A4 (en) | Composite substrate | |
EP3015496A4 (en) | Coating film | |
PL3476591T3 (pl) | Folia kompozytowa |